IBB
Ishares Biotechnology Etf
$215.47
Tue, Nov 3, 2026 close (weekly items: Fri, Oct 30)
Thematic ETF · entry card
APPENDIX · IBB · TECHNICAL TRADING SCORECARD
Scores · Trend 85.0
| RS vs S&P (20) + sector (10) | 20.0 + 1.0 = 21.0 / 30 |
| Structure (6 checks) | 30 / 30 |
| Score = (RS + structure) × 100/60 | 85.0 / 100 |
| Raw state (Up ≥ 60 · Down < 45) | Up |
| Confirmation (2 consecutive Fridays) | confirmed Up |
| Trend (confirmed) | Up |
✔ Fri close above 40-wk SMA 6/6 · ✔ 40-wk SMA rising (4 wks) 4/4 · ✔ No lower high vs cycle high 5/5 · ✔ Fri close above 20-wk SMA 5/5 · ✔ Fri close above 200-wk (4-yr) SMA 5/5 · ✔ 4-mo SMA > 13-mo SMA (completed months, to Sep) 5/5
Weekly raw states: 09-25 Up → 10-02 Up → 10-09 Up → 10-16 Up → 10-23 Up → 10-30 Up. Coppock, band position, breadth and modifiers no longer enter the Trend score (Coppock chart below is reference only). |
Scores · Trading 79.6
| RS (S&P 20 + sector 10) | 20.0 + 4.0 / 30 |
| Structure | 25 / 25 |
| Coppock (daily) — positive & rising | 25.0 / 25 |
| Band position | 5.6 / 20 |
| Raw | 79.6 (Established Up) |
| Modifiers (10-yr > 5% rising −3, seasonal −2) | +0 |
| Final | 79.6 Established Up |
| ✔ Close above 50-day SMA 5/5 · ✔ 50-day SMA rising (10 d) 3/3 · ✔ Close above 100-day SMA 4/4 · ✔ Close above 200-day SMA 5/5 · ✔ 200-day SMA rising (20 d) 3/3 · ✔ No daily lower high (last two swing highs) 5/5 |
Relative state (weekly RS vs 16-wk SMA + 2-wk slope; daily RS vs 15-d SMA + 3-d slope; Neutral ±0.25%; phase price = next Fri / next close, benchmark flat)
| Horizon · benchmark | State | RS vs SMA | RS chg | Phase-transition price (IBB close needed) |
|---|
| Trend · S&P | 1 Established Up (+) → | +8.15% | +8.86% | Est. Up ≥ 202.31 (-6.1%) · Est. Down < 167.45 |
| Trend · XLV | 5 Established Down (+) → | -1.57% | +2.98% | Est. Up ≥ 221.89 (+3.0%) · Est. Down < 220.71 |
| Trading · S&P | 1 Established Up (+) → | +3.77% | +0.88% | Est. Up ≥ 208.81 (-3.1%) · Est. Down < 161.25 |
| Trading · XLV | 3 Neutral (−) ↓ | +0.06% | -1.09% | Est. Up ≥ 221.92 (+3.0%) · Early Up ≥ 215.95 · Est. Down < 214.79 |
Full bands (cluster rule: 2 or more tools within 3%; Δ vs 215.47)
| Band | Range | Distance | Tools in the cluster |
|---|
| R1 | 217.12–222.29 | +0.8% to +3.2% | wk high 08-28 217.12 · ATH 10-30 222.29 |
| S1 | 196.87–200.52 | -6.9% to -8.6% | wk low 09-18 200.52 · wk high 07-10 199.05 · wk low 10-09 196.87 |
| S2 | 179.64–185.19 | -14.1% to -16.6% | 200-day SMA 185.19 · 40-wk SMA 184.85 · wk low 08-07 184.25 · 61.8% 184.14 · wk high 01-09 179.64 |
| S3 | 173.60–178.74 | -17.0% to -19.4% | wk high 01-23 178.74 · wk high 02-27 178.29 · wk high 04-17 177.36 · wk high ’25-11-28 174.40 · wk high 05-08 174.25 · wk high ’25-12-26 173.60 |
| ATH | 222.29 | +3.2% | all-time high; Profit-Taking fallback when no 2-tool band sits above the Breakout (extensions no longer used) |
Coppock, breadth and RS (reference only; not in the Trend score)
Stops & phase transitions
- Tier 1 (trading stop): daily close < 196.87 (-8.6%): trading downgrades one state, re-anchor to S2 179.64–185.19.
- Tier 2 (trend stop = Trend Breakdown / invalidation): Friday close < 179.64 (-16.6%): trend downgrades one state, re-anchor to S3 173.60–178.74.
- Trend vs S&P: Est. Up ≥ 202.31 (-6.1%) · above its 16-wk avg ≥ 202.31 · Est. Down < 167.45 (-22.3%) (next Friday, benchmark flat).
- Trading vs S&P: Est. Up ≥ 208.81 · Est. Down < 161.25.
Sluymer context
- Not named in the 15 reports reviewed (Aug 18 – Oct 13, 2026).
Notes & caveats
Thematic ETFs holding, entry card (treated like the US Watchlist). Holdings: issuer file as of 2026-10-20 (Thematic ETFs bot list: /home/box/thematic-etf-scorecard/latest.json (built 2026-10-21 07:51 PT, from PortfolioDashboardBBG.xlsx MASTER!CK6 'THEMATIC ETFS' block; live at https://skc-thematic-etfs.pages.dev/)); Theme: Biotech. Benchmarks: S&P 500 (20 pts) and XLV (10 pts). Trading items and bands use the Tue, Nov 3, 2026 close; trend uses the Fri, Oct 30 week. Entry levels: Buy Zone = breakout retest zone (BUY names only: from the broken level down to the floor of the resistance band it came from, or level −2%, whichever is tighter; a weekly close below = failed breakout); Breakout Buy Level = top of R1; Trend Breakdown (invalidation) = S2 floor on a Friday close; Profit-Taking = next resistance band above the breakout. Verdict: AVOID = Trend Down (confirmed on two Fridays) or Friday close below a falling 40-wk SMA; BUY = a weekly close above a Breakout Buy Level fixed from the prior week's data with ≥2 tools within 3% (most recent such breakout in the last 4 weeks), every Friday close since and the latest close still at or above it, and Trend not Down; WAIT = otherwise. Buy Zone is reference only. Coppock = 10-bar WMA of ROC(14)+ROC(11), standard settings used as a placeholder because his are unpublished; DAS is omitted. Zone = sign + 3-yr percentile; direction = 2 bars. SMAs are simple; swings are 5-bar extremes; the channel is a 2-yr log regression ±2σ. The breadth proxy is the % of 500 current S&P 500 members with a rising weekly Coppock; it has survivorship bias, is a regime input only, and no other stock was scored. Weights are our choices (playbook §10); the state rule matched 86% / 83% of his sector states in-sample. Data: Yahoo Finance (unadjusted); weight from the Portfolio Dashboard (PIM 11/2 EOD, read-only).
